Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Dialysis01:27

Dialysis

272
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
272
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

527
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
527

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023.

JAMA cardiology·2026
Same author

Association of increased coronary physiology and intracoronary imaging use with downstream healthcare costs.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Cardiovascular Risk Assessment: A Review of Current Models and Emerging Determinants, including Biomarkers, Genetics, and Artificial Intelligence.

Current cardiology reviews·2026
Same author

Efficacy and safety of atrial fibrillation ablation in patients with Marfan syndrome: A multicenter analysis.

Heart rhythm O2·2026
Same author

Artificial Intelligence-Driven Fractional Flow Reserve Assessment: Technical Foundations, Clinical Insights, and Future Directions.

Medicina (Kaunas, Lithuania)·2026
Same author

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026

Related Experiment Video

Updated: Jun 9, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.2K

Kidney Replacement Therapies in Advanced Heart Failure: Timing, Modalities and Clinical Considerations.

Ramzi Ibrahim1, Chelsea Takamatsu1, Abdulla Alabagi1

  • 1Department of Medicine, University of Arizona, Tucson, AZ.

Journal of Cardiac Failure
|October 25, 2024
PubMed
Summary

Acute kidney dysfunction in advanced heart failure (HF) impacts outcomes and treatment decisions. This review explores optimizing kidney replacement therapies (KRTs) for these complex patients.

Keywords:
Heart failuredialysiskidneyrenal

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

500

Related Experiment Videos

Last Updated: Jun 9, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

500

Area of Science:

  • Nephrology
  • Cardiology
  • Critical Care Medicine

Background:

  • Acute kidney dysfunction frequently complicates advanced heart failure (HF), significantly worsening prognosis and survival.
  • This kidney dysfunction influences critical treatment decisions, including eligibility for left ventricular assist device (LVAD) implantation and cardiac transplantation.
  • Kidney replacement therapies (KRTs) are vital but necessitate careful management regarding timing, modality selection, and patient-specific factors.

Purpose of the Study:

  • To review the complexities of implementing KRT in advanced HF patients.
  • To provide guidance on optimizing the timing and selection of KRT modalities.
  • To discuss unique clinical challenges encountered in managing this patient population.

Main Methods:

  • This is a review article.
  • Literature search and synthesis on KRT in advanced HF.
  • Discussion of clinical decision-making frameworks.

Main Results:

  • KRT is essential for managing acute kidney dysfunction in advanced HF.
  • Optimal timing and modality selection for KRT are crucial for patient outcomes.
  • Individualized patient assessment is key to successful KRT implementation.

Conclusions:

  • Effective management of kidney dysfunction with KRT can improve outcomes in advanced HF.
  • Careful consideration of KRT timing, modality, and patient factors is paramount.
  • Further research into tailored KRT strategies for advanced HF is warranted.